|
Volumn 12, Issue 3, 2001, Pages 311-319
|
Clinical impact of histologic subtypes in localized non-anaplastic nephroblastoma treated according to the trial and study SIOP-9/GPOH
a b b c a a d b a e |
Author keywords
Clinical response; Histologic subtype; Nephroblastoma; Preoperative chemotherapy; Prognostic factor; Risk of relapse
|
Indexed keywords
ANTINEOPLASTIC AGENT;
DACTINOMYCIN;
VINCRISTINE;
ADOLESCENT;
ARTICLE;
CANCER RECURRENCE;
CANCER REGISTRY;
CANCER STAGING;
CHILD;
CLINICAL STUDY;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DIAGNOSTIC IMAGING;
DRUG RESPONSE;
FEMALE;
HISTOPATHOLOGY;
HUMAN;
HUMAN TISSUE;
INFANT;
MAJOR CLINICAL STUDY;
MALE;
MEDICAL SOCIETY;
NEPHROBLASTOMA;
PREOPERATIVE CARE;
PRIORITY JOURNAL;
PROSPECTIVE STUDY;
TREATMENT OUTCOME;
TUMOR DIFFERENTIATION;
TUMOR LOCALIZATION;
TUMOR NECROSIS;
TUMOR REGRESSION;
|
EID: 0035073085
PISSN: 09237534
EISSN: None
Source Type: Journal
DOI: 10.1023/A:1011167924230 Document Type: Article |
Times cited : (132)
|
References (40)
|